Page 44 - ESHRE2019
P. 44
Conclusive remarks
• Low access to assisted reproducive technologies worldwide
• Huge difference between countries / continents
• Costs associated with ART/infertility care have to decrease
• Diagnostics
• Medication
• Laboratory
• Reimbursement policies should be discussed
• Awareness: urgent need for involvement of NGOs, Foundations, governments, health care providers
42
39
